FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR
Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy
Spider-Man: Brand New Day’s Gene-Silencing Technology: Could It Fight Cancer?
LITESPARK-011 Trial: Belzutifan Plus Lenvatinib vs Cabozantinib in Advanced RCC
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg
Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll
Lucy Davis Reveals Incurable Stage 4 Breast Cancer: Diagnosis, Bone Metastases, and What We Know
BMS Team Celebrates Accelerated FDA Approval for Multiple Myeloma
JADPRO Live 2026, organized by Conexiant in collaboration with the Advanced Practitioner Society for Hematology and Oncology (APSHO), will take place on 15–18 October 2026 at the Minneapolis Convention Center […]
